Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
YishenShujin Decoction
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Fibromyalgia Syndrome
1 trial -
ZS801
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hemophilia B
1 trial -
ZS802
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hemophilia A
1 trial -
ZhenQi BuXue KouFuYe
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Menstrual Disorders
1 trial -
Zinc gluconate
Grace Therapeutics
HIV
1 trial -
[68Ga]P3
The First People's Hospital of Lianyungang
Neoplasms
1 trial -
active tDCS and cognitive training intervention
United Therapeutics Europe Ltd
Brain Concussion
2 trials -
adefovir dipivoxil
Hospital Authority, Hong Kong
Hepatitis B
1 trial -
alteplase or tenecteplase
United Therapeutics Europe Ltd
CVA (Cerebrovascular Accident)
1 trial -
anti-CD19/BCMA-UCAR-T cells
The First People's Hospital of Lianyungang
Rheumatoid Arthritis
1 trial -
anti-PD-1 / PD-L1 monoclonal antibody and chemotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Effect Increased
1 trial -
anti-thymocyte globulin
Ultragenyx UK Limited
Chediak-Higashi Syndrome
1 trial -
anti-thymocyte globulin
United Therapeutics Europe Ltd
Leukemia
1 trial -
anti-thymocyte globulin
Ultragenyx UK Limited
Purpura, Schoenlein-Henoch
1 trial -
antihistamine(low dose) chlorpheniramine (Dexchlorpheniramine maleate)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pain
1 trial -
bicycle ergometry test with spiroergometry
The First People's Hospital of Lianyungang
Community-acquired Pneumonia
1 trial -
bismuth-containing quadral therapy based on antibiotic susceptibility
Shandong University
Helicobacter Pylori
1 trial -
blood draw from three different vessels
Sionna Therapeutics
Accidental Hypothermia
1 trial -
blood sampling
Marker Therapeutics
Screening for Colon Cancer
1 trial -
blood sampling
Marker Therapeutics
Colorectal Cancer Screening
1 trial -
bpMRI
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
brachytherapy
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
carotid-femoral pulse-wave velocity
Structure Therapeutics
Covid19
1 trial -
chemotherapy
United Therapeutics Europe Ltd
Malignant Mesothelioma
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources